GreenLight Biosciences- Warrants (30/09/2027) Profit Margin

As of the most recent data (March 2023), GRNAW shows a profit margin of -1549.12%. That compares with -12584.61% in the prior-year period — up 87.7% year over year. That is below the sector sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRNAW's profit margin is now -1549.12% (was -12584.61%) — a 87.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences- Warrants (30/09/2027) is outperforming or lagging.

The its sector sector average profit margin is about 21.34%. GreenLight Biosciences- Warrants (30/09/2027) is at -1549.12%, which is lower that average. That is roughly 7358.6% below the sector mean. Use the comparison chart on this page to see how GRNAW stacks up against individual peers as well.

That compares with -12584.61% in the prior-year period — up 87.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare GreenLight Biosciences- Warrants (30/09/2027) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has GreenLight Biosciences- Warrants (30/09/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -1549.12%) with ownership activity and broader fundamentals.